2023 Angiogenesis Gordon Research Conference and Seminar

2023年血管生成戈登研究会议暨研讨会

• 批准号: 10753606
• 负责人: Ondine B Cleaver
• 金额: $ 2万
• 依托单位: GORDON RESEARCH CONFERENCES
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-07-27 至 2024-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10753606
• 关键词: Academia; Address; Affect; Aging; Architecture; Awareness; Basic Science; Big Data; Biological Markers; Biology; Biomechanics; Blood Vessels; Cardiovascular Diseases; Cell Therapy; Cells; Chronic; Collaborations; Communication; Cues; Data; Development; Dimensions; Disease; Disease Progression; Endothelial Cells; Endothelium; Ensure; Environment; Exposure to; Female; Fostering; Funding; Future; Gatekeeping; Generations; Genetic Engineering; Goals; Growth; Health; Heterogeneity; Human; Image; Industry; International; Knowledge; Learning; Life; Maintenance; Malignant Neoplasms; Medicine; Microfluidics; Modality; Modeling; Molecular; Molecular Analysis; Morphology; Natural regeneration; Ointments; Organ; Organoids; Participant; Peer Group; Physiological; Postdoctoral Fellow; Pre-Clinical Model; Records; Regenerative Medicine; Research; Research Personnel; Rhode Island; Running; Schedule; Science; Scientist; Senior Scientist; Signal Pathway; Signaling Molecule; Solid; Source; Stimulus; Stroke; Structure; Students; System; Systems Biology; Technology; Therapeutic; Tissue Engineering; Tissues; Translating; Translations; United States National Institutes of Health; Universities; Vascular Diseases; Vocational Guidance; Woman; Work; angiogenesis; assault; bench to bedside; combat; data exchange; demographics; design; diagnostic tool; driving force; expectation; experience; genome-wide; graduate student; hemodynamics; international scientific organization; malformation; meetings; new technology; next generation; non-genetic; novel; organ regeneration; personalized medicine; pre-doctoral; regenerative tissue; response; single cell sequencing; single cell technology; social; stem cell biology; stem cells; success; symposium; targeted treatment; technology development; tissue regeneration; tool; transcriptomics; translational approach; vascular tissue engineering; willingness

Project Summary/Abstract This Angiogenesis Gordon Research Conference (GRC), “Angiogenesis and angiostability in development, disease and engineered tissues”, and the accompanying Gordon Research Seminar (GRS, organized by and for trainees) “Harnessing developmental angiogenesis to instruct cell therapies and regenerative medicine” are designed to address the underlying hypothesis that the vast heterogeneity of blood vessels is underlain by unique molecular and cellular mechanisms ensuring their proper formation and stability. A better understanding of how and why blood vessels of different organs, sizes, and morphologies grow and maintain their architecture, despite being under unrelenting hemodynamic assault, is critical to inform vascularization of engineered or regenerating tissues and to normalizing vascular malformations. The goals of the conference are, therefore, to bridge existing knowledge and communication gaps between researchers at all levels (students, postdocs, junior and senior scientists in academia and industry) who study angiogenesis and angiostability and those focusing on vascular diseases, stem cell biology and disease- associated vascular dysfunction, including cancer, cardiovascular diseases, and stroke. These fields have recently developed paradigms, tools, and models to aid this goal, and this integration is predicted to move science forward toward the timely translation of basic discoveries. A complimentary GRS pre-meeting will also be included and will be organized by trainees and for trainees. The GRS will feature trainee work presentations to facilitate networking, and provide them with a peer group as they transition into the main meeting. The GRC Chair and Vice-Chair are two female scientists in the field with strong scientific track records and substantial experience in the organization of international scientific meetings. The meeting goals will be accomplished by bringing together a selected group of researchers (about 180 participants) at Salve Regina University, Newport, Rhode Island, for a week from July 30 to August 3rd, 2023. The choice of this venue is based on solid precedent, as this meeting has taken place every two years since 1995 and has proven an ideal setting for the Angiogenesis GRC. The venue and meeting structure are designed to foster extensive discussion in response to presentations of largely unpublished data and to promote informal networking through shared meals and afternoon social activities. Invited speakers are chosen based on excellence in research, topic, and willingness to engage trainees. Participants will specifically be selected to reflect the broad demographics of scientists working in the field. Women currently comprise 53% of confirmed speakers and discussion leaders. Overall, this GRC/GRS will foster lasting interdisciplinary interactions and collaborations amongst NIH-funded and international vascular and stem cell biologists, between academic and industry scientists, and will develop the next cadre of scientists at the intersection of these fields. The design of the meeting will have a lasting impact as it tackles crucial questions in health and disease in angiogenesis research.

项目总结/摘要 血管生成戈登研究会议（GRC），“血管生成和血管稳定性， 发展，疾病和工程组织”，以及随之而来的戈登研究研讨会（GRS， “利用发育性血管生成指导细胞疗法， 再生医学”旨在解决潜在的假设，即血液的巨大异质性 血管是由独特的分子和细胞机制，确保其正确的形成和稳定性。 更好地了解不同器官、大小和形态的血管如何以及为什么生长， 尽管受到无情的血流动力学攻击，但保持其结构至关重要， 工程化或再生组织的血管化以及使血管畸形正常化。 因此，会议的目标是弥合现有的知识和沟通差距 各级研究人员（学生，博士后，学术界和工业界的初级和高级科学家）之间的联系， 研究血管生成和血管稳定性，以及专注于血管疾病，干细胞生物学和疾病- 相关的血管功能障碍，包括癌症、心血管疾病和中风。这些领域 最近开发的范例，工具和模型来帮助实现这一目标，预计这种集成将 科学朝着及时转化基本发现的方向前进。免费的GRS会前会议也将 将由受训人员和为受训人员举办。GRS将以学员工作演示为特色 促进建立网络，并在他们过渡到主要会议时为他们提供一个同行小组。 GRC主席和副主席是该领域的两位女性科学家，具有良好的科学记录 在组织国际科学会议方面有丰富的经验。会议的目标将是 通过将一组选定的研究人员（约180名参与者）聚集在Salve Regina 大学，纽波特，罗得岛，为期一周，从2023年7月30日至8月3日。选择这个地点是基于 这一会议自1995年以来每两年举行一次，已证明是一个理想的环境， 血管生成GRC会场和会议结构的设计是为了促进广泛的讨论 针对提交的大部分未公布的数据， 分享食物和下午的社交活动。受邀演讲者的选择是基于卓越的研究， 主题，并愿意参与学员。与会者将专门挑选，以反映广泛的 在该领域工作的科学家的人口统计数据。妇女目前占确认发言者的53%， 讨论领导者。总体而言，该GRC/GRS将促进持久的跨学科互动和合作 在NIH资助的和国际血管和干细胞生物学家之间，在学术界和工业界之间， 科学家，并将在这些领域的交叉点发展下一批科学家。的设计 会议将产生持久的影响，因为它解决了血管生成研究中健康和疾病的关键问题。